Market Closed -
Sao Paulo
01:37:49 27/04/2024 am IST
|
5-day change
|
1st Jan Change
|
25.85
BRL
|
+3.61%
|
|
+5.73%
|
-10.12%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,32,664
|
88,380
|
66,643
|
64,842
|
58,282
|
-
|
-
|
Enterprise Value (EV)
1 |
1,46,263
|
1,08,214
|
74,687
|
71,208
|
69,461
|
65,528
|
65,406
|
P/E ratio
|
311
x
|
56.3
x
|
55.9
x
|
31.8
x
|
20
x
|
15.3
x
|
12.1
x
|
Yield
|
0.08%
|
0.73%
|
1.18%
|
1.26%
|
1.29%
|
1.52%
|
2.44%
|
Capitalization / Revenue
|
9.46
x
|
4.34
x
|
2.9
x
|
1.39
x
|
1.1
x
|
1.01
x
|
0.9
x
|
EV / Revenue
|
10.4
x
|
5.31
x
|
3.25
x
|
1.53
x
|
1.31
x
|
1.13
x
|
1.01
x
|
EV / EBITDA
|
46
x
|
19
x
|
12.6
x
|
9.68
x
|
8.75
x
|
7.05
x
|
6.05
x
|
EV / FCF
|
-143
x
|
-48.1
x
|
-64.5
x
|
-34.3
x
|
21.3
x
|
16.5
x
|
13.3
x
|
FCF Yield
|
-0.7%
|
-2.08%
|
-1.55%
|
-2.91%
|
4.69%
|
6.05%
|
7.51%
|
Price to Book
|
9.75
x
|
6.51
x
|
3.06
x
|
2.88
x
|
2.31
x
|
2.1
x
|
-
|
Nbr of stocks (in thousands)
|
19,42,366
|
19,71,453
|
22,52,958
|
22,54,607
|
22,54,607
|
-
|
-
|
Reference price
2 |
68.30
|
44.83
|
29.58
|
28.76
|
25.85
|
25.85
|
25.85
|
Announcement Date
|
24/02/21
|
29/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
14,029
|
20,382
|
22,987
|
46,509
|
52,976
|
57,901
|
64,702
|
EBITDA
1 |
3,179
|
5,696
|
5,907
|
7,354
|
7,934
|
9,292
|
10,808
|
EBIT
1 |
1,637
|
3,668
|
3,899
|
4,491
|
5,919
|
7,137
|
8,768
|
Operating Margin
|
11.67%
|
18%
|
16.96%
|
9.66%
|
11.17%
|
12.33%
|
13.55%
|
Earnings before Tax (EBT)
1 |
483.5
|
2,033
|
1,325
|
2,674
|
4,000
|
5,244
|
6,312
|
Net income
1 |
428.3
|
1,575
|
1,195
|
2,095
|
2,934
|
3,794
|
4,543
|
Net margin
|
3.05%
|
7.73%
|
5.2%
|
4.5%
|
5.54%
|
6.55%
|
7.02%
|
EPS
2 |
0.2198
|
0.7968
|
0.5290
|
0.9051
|
1.290
|
1.687
|
2.143
|
Free Cash Flow
1 |
-1,022
|
-2,248
|
-1,158
|
-2,074
|
3,259
|
3,962
|
4,911
|
FCF margin
|
-7.29%
|
-11.03%
|
-5.04%
|
-4.46%
|
6.15%
|
6.84%
|
7.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
41.07%
|
42.64%
|
45.44%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
111.07%
|
104.43%
|
108.1%
|
Dividend per Share
2 |
0.0539
|
0.3268
|
0.3495
|
0.3637
|
0.3332
|
0.3917
|
0.6312
|
Announcement Date
|
24/02/21
|
29/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
5,308
|
5,136
|
5,373
|
5,799
|
6,063
|
5,752
|
4,915
|
11,679
|
11,812
|
11,812
|
13,244
|
14,197
|
14,619
|
14,632
|
EBITDA
1 |
1,514
|
1,285
|
1,317
|
1,580
|
1,657
|
1,353
|
1,347
|
1,615
|
1,912
|
1,772
|
1,835
|
2,204
|
2,203
|
2,101
|
EBIT
1 |
936.4
|
924.1
|
793.5
|
846.2
|
1,163
|
878.5
|
866.3
|
1,122
|
1,414
|
1,088
|
1,308
|
1,460
|
1,453
|
1,336
|
Operating Margin
|
17.64%
|
17.99%
|
14.77%
|
14.59%
|
19.18%
|
15.27%
|
17.63%
|
9.61%
|
11.97%
|
9.21%
|
9.88%
|
10.29%
|
9.94%
|
9.13%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
327.5
|
616.4
|
980.7
|
749.4
|
856.1
|
1,019
|
1,018
|
902.3
|
Net income
1 |
351
|
406.4
|
-
|
-
|
375.3
|
215.1
|
287.4
|
408.5
|
753.8
|
644.8
|
644.5
|
735.8
|
769.6
|
652.9
|
Net margin
|
6.61%
|
7.91%
|
-
|
-
|
6.19%
|
3.74%
|
5.85%
|
3.5%
|
6.38%
|
5.46%
|
4.87%
|
5.18%
|
5.26%
|
4.46%
|
EPS
2 |
0.1746
|
0.2056
|
0.1064
|
0.1714
|
0.1899
|
0.0610
|
0.1272
|
0.1812
|
0.3344
|
0.2621
|
0.2572
|
0.3138
|
0.3654
|
0.3426
|
Dividend per Share
2 |
1.080
|
0.0944
|
0.1969
|
0.0500
|
-
|
0.0800
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.3153
|
Announcement Date
|
04/11/21
|
29/03/22
|
13/05/22
|
15/08/22
|
09/11/22
|
27/03/23
|
16/05/23
|
09/08/23
|
08/11/23
|
27/03/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
13,600
|
19,834
|
8,044
|
6,365
|
11,179
|
7,247
|
7,124
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.278
x
|
3.482
x
|
1.362
x
|
0.8655
x
|
1.409
x
|
0.7798
x
|
0.6591
x
|
Free Cash Flow
1 |
-1,022
|
-2,248
|
-1,158
|
-2,074
|
3,259
|
3,962
|
4,911
|
ROE (net income / shareholders' equity)
|
4.55%
|
11.6%
|
6.75%
|
9.52%
|
11.8%
|
15.1%
|
17.5%
|
ROA (Net income/ Total Assets)
|
1.19%
|
3.21%
|
-
|
2.37%
|
3.23%
|
4.1%
|
-
|
Assets
1 |
36,143
|
49,069
|
-
|
88,510
|
90,786
|
92,557
|
-
|
Book Value Per Share
2 |
7.010
|
6.890
|
9.680
|
10.00
|
11.20
|
12.30
|
-
|
Cash Flow per Share
2 |
-0.0400
|
-0.0600
|
0.5800
|
0.1800
|
1.540
|
-
|
-
|
Capex
1 |
945
|
2,127
|
2,476
|
2,470
|
2,519
|
2,064
|
1,884
|
Capex / Sales
|
6.74%
|
10.43%
|
10.77%
|
5.31%
|
4.75%
|
3.56%
|
2.91%
|
Announcement Date
|
24/02/21
|
29/03/22
|
27/03/23
|
27/03/24
|
-
|
-
|
-
|
Last Close Price
25.85
BRL Average target price
33.73
BRL Spread / Average Target +30.47% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.12% | 11.37B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|